duet multiomic solution evoC (6-base) workshop Co-sponsored by biomodal and Illumina

Reveal the power of the 6-base genome – Introducing, duet multiomics solution evoC

This workshop will take place at the Illumina Solution Center in Baltimore, MD

801 W Baltimore Street,
Suite 500
Baltimore, MD 21201

30 July 2024
 to 2 August 2024
Illumina, Baltimore


Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all 4 canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment.

The 6-base genome enables multidimensional DNA methylation analysis for biomarker discovery to gain transformative insights into current and future states of disease.

Sign up for this workshop if you are interested in getting your hands on the only technology providing simultaneous genome and epigenome data. biomodal duet multiomics solution evoC assay reagents and hands-on training will be provided.

Please register below; you must fill out the additional survey.

Workshop size is limited to 10 participants so don’t delay.

Day 1

Tuesday, July 30th – Start time is 12:00pm EST

  • Introductions
  • duet multiomics solution evoC Technical Presentation and agenda review for days 2-4
  • Lunch will be provided

Days 2-4

Wednesday, July 31st – Friday, August 2nd, start time is 9:00am EST

  • Technical training
  • Lunch will be provided

For those that are submitting workshop requests, the following sample requirements should be considered;

  • gDNA: mechanically fragmented to 250 bp
  • FFPE DNA samples: please note that in the details about your research project
  • cfDNA: no fragmentation required
  • Perform BioA or TapeStation traces on post-shear samples
  • Qubit quantification post-shear samples
  • Dilute 5 – 20 ng (cfDNA) or 10 – 80 ng (gDNA) in 24 uL low TE
    • This is the minimum. Results may vary.
  • Store DNA at -20C until Day 2

Questions?  Please contact your local Illumina or biomodal rep:

Rachel Troppman
Illumina Account Manager

John McShane
Director of Business Development


Mark Consugar

Lead Field Application Scientist


Register your interest

Cambridge Epigenetix is now biomodal